Product Name: Dopamine Receptor D3 antibody
Applications: IHC-P
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Immunogen affinity purified
Full Name: Dopamine receptor D3
Background: The DRD3 Dopamine Receptor is expressed in brain regions associated with cognitive, emotional, and endocrine functions. DRD3 mediates the effects of drugs used in the treatment of schizophrenia and Parkinsons disease. DRD3 also binds BP897, a potent inhibitor of drug-craving and cocaine-seeking behaviors. Mutations in DRD3 lead to sodium retention in the kidney, resulting in hypertension and increased locomotor activity in mice. Multiple isoforms of DRD3 are produced by alternative splicing.
Synonyms: Drd1, Drd1a, DRD3, 1814, D(1A) dopamine receptor
Cellular Localization:
CAS NO: 129101-54-8
Product: VcMMAE
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Synthetic peptide – KLH conjugated corresponding to 3rd cytoplasmic domain of human
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: PBS
Storage Instruction: Store at 4C short term. Aliquot and store at -80C long term. Avoid freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: Third cytoplasmic domain of DRD3
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19712103?dopt=Abstract
